ARTICLE | Clinical News
Cholestagel regulatory update
October 3, 2011 7:00 AM UTC
Valeant Pharmaceuticals International Inc. (NYSE:VRX; TSX;VRX, Mississauga, Ontario) said Health Canada approved an NDS for Cholestagel colesevelam to treat hypercholesterolemia. In February, Sanofi'...